Aier Eye Hospital Group Co Ltd banner
A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 8.6 CNY 7.5%
Market Cap: ¥80.2B

Intrinsic Value

The intrinsic value for Aier Eye Hospital Group Co Ltd (300015) under the Base Case is 12.87 CNY. Compared with the current market price of 8.6 CNY, the stock appears Undervalued by 33% .

Based on two methods:

Both DCF and multiples point to undervaluation.

Intrinsic Value
12.87 CNY
Undervaluation 33%
Intrinsic Value
Price ¥8.6
A
Bear Case
Base Case
Bull Case
Monitor Aier Eye Hospital Group Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥10.29
Get notified when the price drops into your buy zone
Intrinsic Value ¥12.87
Margin of Safety 20% ¥10.29
Current Price ¥8.6
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about Aier Eye Hospital Group Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Aier Eye Hospital Group Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Aier Eye Hospital Group Co Ltd.

Explain Valuation
Alternatives to Aier Eye Hospital Group Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Aier Eye Hospital Group Co Ltd stock?

The intrinsic value for Aier Eye Hospital Group Co Ltd (300015) under the Base Case is 12.87 CNY.

Is Aier Eye Hospital Group Co Ltd stock undervalued or overvalued?

Compared with the current market price of 8.6 CNY, the stock appears Undervalued by 33% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett